Search

everythinglearnresearchcommunity

for

Search:↓

Blocking miR-27a increases sheep hair follicle stem cell growth and decreases cell death, which could help improve wool quality and treat hair loss.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

A specific RNA helps increase the growth of skin cells in Liaoning cashmere goats by working with a protein to boost a growth-related gene.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

The study suggests that complement activation, not immunoglobulins, may be important in erythema nodosum leprosum.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

Lnc056 helps hair follicle stem cells grow by increasing TRIP6 expression.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

ZDHHC13 is important for normal liver function and metabolism, affecting mitochondrial activity.

Monilethrix is linked to a gene cluster on chromosome 12.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

CLEC10A and interleukin-42 can help identify PCOS patients' response to Metformin treatment.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

Alopecia areata involves specific immune cells, offering potential treatment targets.

A 3-month treatment improved PCOS symptoms and reduced certain immune proteins.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Deleting TNFα gene reduces skin cancer risk in certain mice.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

p2y5, now called LPA6, is a receptor important for human hair growth.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.